BB Biotech AG : Publication pursuant to Â§26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution
BB Biotech AG /
BB Biotech AG : Publication pursuant to Â§26 sect.1 WpHG (the German Securities
Trading Act) with the aim of pan-European distribution
. Ad hoc announcement according to Â§ 15 WpHG. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Pursuant to article 26 sec 1 clause 2 WpHG, BB Biotech AG, Schaffhausen,
Switzerland, herby reports that it decreased its holding in own shares to below
3% of the proportion of voting rights as of September 19, 2013 (a total of
342 246 shares / 2.89% of the proportion of voting rights).
Thereof, 0.63% of the proportion of voting rights (a total of 74 746 shares) are
held through its wholly-owned subsidiary Biotech Target N.V., CuraÃ§ao.
For further information: Bellevue Asset Management AG, Seestrasse 16, 8700
KÃ¼snacht / ZÃ¼rich
Tanja Chicherio, Tel. +41 44 267 67 00.
Schaffhausen, September 24, 2013
BB Biotech AG
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BB Biotech AG via Thomson Reuters ONE